These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 26001244)

  • 1. Chemoembolization of recurrent hepatoma after curative resection: prognostic factors.
    Zu QQ; Liu S; Zhou CG; Yang ZQ; Xia JG; Zhao LB; Shi HB
    AJR Am J Roentgenol; 2015 Jun; 204(6):1322-8. PubMed ID: 26001244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.
    Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.
    Luo J; Peng ZW; Guo RP; Zhang YQ; Li JQ; Chen MS; Shi M
    Radiology; 2011 Apr; 259(1):286-95. PubMed ID: 21330557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
    World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection.
    Meniconi RL; Komatsu S; Perdigao F; Boëlle PY; Soubrane O; Scatton O
    Surgery; 2015 Mar; 157(3):454-62. PubMed ID: 25633732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization as first-line therapy for hepatocellular carcinomas infeasible for ultrasound-guided radiofrequency ablation: a retrospective cohort study of 116 patients.
    Song YG; Shin SW; Cho SK; Choi D; Rhim H; Lee MW; Kim YS; Park KB; Park HS; Choo SW; Do YS; Choo IW; Hyun D
    Acta Radiol; 2015 Jan; 56(1):70-7. PubMed ID: 24518688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of chemoembolization for recurrent HCC after curative ablation therapy.
    Okabe N; Morimoto M; Kondo M; Moriya S; Numata K; Maeda S; Tanaka K
    Hepatogastroenterology; 2013 May; 60(123):395-99. PubMed ID: 23108088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
    Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
    World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
    Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
    Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
    Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
    Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.
    Choi JW; Park JY; Ahn SH; Yoon KT; Ko HK; Lee DY; Lee JT; Kim KS; Choi JS; Han KH; Chon CY; Kim DY
    Am J Clin Oncol; 2009 Dec; 32(6):564-9. PubMed ID: 19564783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of hepatic resection and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria].
    Guo Z; Xiang B; Zhang J; Jiang J; Li L
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(20):1526-9. PubMed ID: 25146737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.